News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
221,520 Results
Type
Article (4986)
Company Profile (22)
Press Release (216512)
Section
Business (82190)
Career Advice (461)
Deals (15039)
Drug Delivery (8)
Drug Development (19058)
Employer Resources (30)
FDA (3672)
Job Trends (3896)
News (120087)
Policy (7499)
Tag
Academia (292)
Alliances (14697)
Alzheimer's disease (215)
Approvals (3667)
Bankruptcy (94)
Best Places to Work (2848)
Biotechnology (24)
Breast cancer (21)
Cancer (244)
Career advice (391)
Cell therapy (55)
Clinical research (15685)
Collaboration (84)
Compensation (67)
COVID-19 (293)
C-suite (46)
Data (289)
Diabetes (24)
Diagnostics (1996)
Earnings (39984)
Employer resources (31)
Events (36955)
Executive appointments (135)
FDA (3782)
Funding (93)
Gene therapy (25)
GLP-1 (97)
Government (406)
Healthcare (5019)
Infectious disease (304)
Inflammatory bowel disease (22)
Interviews (53)
IPO (7737)
Job creations (1120)
Job search strategy (360)
Layoffs (95)
Legal (2322)
Lung cancer (26)
Manufacturing (28)
Medical device (3816)
Medtech (3817)
Mergers & acquisitions (7343)
Metabolic disorders (74)
Neuroscience (260)
NextGen Class of 2024 (1671)
Non-profit (725)
Northern California (530)
Obesity (36)
Opinion (28)
People (24176)
Phase I (4675)
Phase II (6818)
Phase III (5412)
Pipeline (263)
Postmarket research (625)
Preclinical (1833)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (38)
Real estate (1869)
Regulatory (4982)
Research institute (298)
Resumes & cover letters (68)
Southern California (405)
Startups (1007)
United States (4228)
Vaccines (28)
Date
Today (29)
Last 7 days (173)
Last 30 days (1271)
Last 365 days (11154)
2024 (10331)
2023 (13211)
2022 (18659)
2021 (19681)
2020 (18239)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9157)
2015 (12119)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8797)
2010 (8634)
Location
Africa (182)
Arizona (49)
Asia (11285)
Australia (1558)
California (1083)
Canada (456)
China (30)
Colorado (42)
Connecticut (56)
Europe (23969)
Florida (139)
Georgia (22)
Idaho (23)
Illinois (75)
Indiana (35)
Japan (30)
Kansas (23)
Maine (34)
Maryland (138)
Massachusetts (898)
Michigan (60)
Minnesota (98)
New Jersey (336)
New York (302)
North Carolina (239)
Northern California (530)
Ohio (36)
Pennsylvania (227)
South America (273)
Southern California (405)
Texas (128)
Utah (31)
Washington State (98)
221,520 Results for "cancervax corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CancerVax Lands Top Cancer Expert
November 19, 2024
·
3 min read
BioMidwest
CancerVax Launches $5 Million Funding Round
CancerVax, Inc., developer of a breakthrough Universal Cancer Vaccine treatment that will use the body’s immune system to fight cancer, announced that its Reg A+ offering has been qualified by the SEC allowing the Company to formally launch a funding round of up to $5 million.
April 3, 2024
·
3 min read
Biotech Beach
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, announced that its UCLA research team has achieved a critical milestone by creating a process to add any antibody to lipid nanoparticles using “click chemistry”, for targeting cancer cells.
May 21, 2024
·
4 min read
Policy
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, announced that its UCLA research team has created a promising new drug candidate for treating recurrent Ewing sarcoma, a deadly children’s cancer.
April 16, 2024
·
4 min read
Press Releases
CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
August 29, 2024
·
4 min read
Press Releases
CancerVax Adds Key Members to Its Research Team
August 1, 2024
·
3 min read
Press Releases
CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform
August 27, 2024
·
5 min read
Business
World Renowned Biomedical Professor Jonathan Lakey Joins CancerVAX Board of Advisors
CancerVAX, developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, reported that the Company has appointed Dr. Jonathan Lakey to CancerVAX’s Board of Advisors.
July 26, 2023
·
4 min read
Business
CancerVAX CEO Ryan Davies Discusses the Company’s Growing Pipeline of Cancer Treatments
CancerVAX, Inc. announced that in a recent podcast its CEO, Ryan Davies, spoke about the Company’s growing pipeline of cancer treatments under development at UCLA.
September 14, 2023
·
3 min read
BioMidwest
CancerVAX Expands Development Pipeline to Include a Universal CAR-T Cell Platform
CancerVAX, Inc. announced an expansion of its development pipeline to include a Universal CAR-T Cell Platform that can dramatically lower the cost of CAR-T cell cancer therapies.
September 12, 2023
·
5 min read
1 of 22,152
Next
